PSA (total and free)

Measures the ratio of free PSA (not bound to proteins) to PSA bound to proteins. This improves the accuracy of prostate cancer screening and helps distinguish between cancer and benign prostate conditions such as benign prostatic hyperplasia (BPH). Eligibility: anyone with a prostate, of any age.